CGMS | JPIB | CGMS / JPIB | |
Gain YTD | 6.541 | 3.431 | 191% |
Net Assets | 1.69B | 498M | 339% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 43.00 | 71.00 | 61% |
Yield | 6.01 | 4.43 | 136% |
Fund Existence | 2 years | 8 years | - |
CGMS | JPIB | |
---|---|---|
RSI ODDS (%) | N/A | 3 days ago53% |
Stochastic ODDS (%) | 3 days ago48% | 3 days ago52% |
Momentum ODDS (%) | 3 days ago77% | 3 days ago50% |
MACD ODDS (%) | 3 days ago79% | 3 days ago46% |
TrendWeek ODDS (%) | 3 days ago37% | 3 days ago39% |
TrendMonth ODDS (%) | 3 days ago29% | 3 days ago41% |
Advances ODDS (%) | 10 days ago78% | 10 days ago57% |
Declines ODDS (%) | 3 days ago40% | 6 days ago42% |
BollingerBands ODDS (%) | 3 days ago44% | N/A |
Aroon ODDS (%) | 3 days ago27% | 3 days ago43% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CIBFX | 71.86 | -0.32 | -0.44% |
American Funds Capital Income Bldr F1 | |||
PILIX | 11.15 | -0.06 | -0.54% |
Principal International Equity Index R1 | |||
FAOAX | 31.93 | -0.41 | -1.27% |
Fidelity Advisor Overseas A | |||
CTYRX | 90.89 | -2.38 | -2.55% |
Columbia Global Technology Growth Adv | |||
RYCFX | 49.93 | -2.32 | -4.44% |
Rydex Biotechnology C |
A.I.dvisor tells us that CGMS and DBD have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGMS and DBD's prices will move in lockstep.
Ticker / NAME | Correlation To CGMS | 1D Price Change % | ||
---|---|---|---|---|
CGMS | 100% | -0.04% | ||
DBD - CGMS | 12% Poorly correlated | +3.76% |